Notícias e Atividades da Aspira Women’s Health

Aspira Women’s Health é uma empresa listada sob o símbolo AWH (US).

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da Aspira Women’s Health

• Mike Buhle, Chief Executive Officer
• Jeffrey Cohen, Director
• Jack Fraser, Chairman of the Board

Recentes movimentos de executivos em Aspira Women’s Health

• John Strahley, ingressou na Companhia como Chief Financial Officer  (Notícia publicada em 31 de maio de 2026).

Criar um alerta
para seguir os movimentos de executivos da Aspira Women’s Health.

Aspira Women’s Health possui 1.235 concorrentes concorrentes Thermo Fisher Scientific (Estados Unidos), Medtronic (Irlanda) e Philips (Holanda).

Popular M&A news in Equipamentos Médicos

• CereVasc acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 7 de junho de 2026).
• Fonar Corporation, listado sob o ticker FONR, foi retirado da bolsa. (publicado em 7 de junho de 2026).
• Bridgepoint has announced the acquisition of Obagi Medical Products  (publicado em 4 de junho de 2026).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio da Medtronic
• Ivan Tornos - Chairman, President and Chief Executive Officer da Zimmer Biomet
• Jacob Thaysen - Chief Executive Officer and Director da Illumina

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

Redes sociais sobre Aspira Women’s Health

• Aspira Women’s Health na Wikipedia, Google News e Yahoo Finance
• Aspira Women’s Health na LinkedIn, X (Twitter) e YouTube